Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 49


Progress toward strengthening national blood transfusion services--14 countries, 2008-2010.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 Nov 25;60(46):1577-82.


Diagnosis of Burkitt lymphoma using an algorithmic approach--applicable in both resource-poor and resource-rich countries.

Naresh KN, Ibrahim HA, Lazzi S, Rince P, Onorati M, Ambrosio MR, Bilhou-Nabera C, Amen F, Reid A, Mawanda M, Calbi V, Ogwang M, Rogena E, Byakika B, Sayed S, Moshi E, Mwakigonja A, Raphael M, Magrath I, Leoncini L.

Br J Haematol. 2011 Sep;154(6):770-6. doi: 10.1111/j.1365-2141.2011.08771.x. Epub 2011 Jul 1.


Lymphomas in sub-Saharan Africa--what can we learn and how can we help in improving diagnosis, managing patients and fostering translational research?

Naresh KN, Raphael M, Ayers L, Hurwitz N, Calbi V, Rogena E, Sayed S, Sherman O, Ibrahim HA, Lazzi S, Mourmouras V, Rince P, Githanga J, Byakika B, Moshi E, Durosinmi M, Olasode BJ, Oluwasola OA, Akang EE, Akenòva Y, Adde M, Magrath I, Leoncini L.

Br J Haematol. 2011 Sep;154(6):696-703. doi: 10.1111/j.1365-2141.2011.08772.x. Epub 2011 Jun 28. Review.


The effect of prophylactic lamivudine on hepatitis B virus reactivation in HBsAg-positive patients with diffuse large B-cell lymphoma undergoing prolonged rituximab therapy.

Chen XQ, Peng JW, Lin GN, Li M, Xia ZJ.

Med Oncol. 2012 Jun;29(2):1237-41. doi: 10.1007/s12032-011-9974-0. Epub 2011 May 10.


Cancer burden in the HIV-infected population in the United States.

Shiels MS, Pfeiffer RM, Gail MH, Hall HI, Li J, Chaturvedi AK, Bhatia K, Uldrick TS, Yarchoan R, Goedert JJ, Engels EA.

J Natl Cancer Inst. 2011 May 4;103(9):753-62. doi: 10.1093/jnci/djr076. Epub 2011 Apr 11.


Predictors of survival after a diagnosis of non-Hodgkin lymphoma in a resource-limited setting: a retrospective study on the impact of HIV infection and its treatment.

Bateganya MH, Stanaway J, Brentlinger PE, Magaret AS, Wald A, Orem J, Casper C.

J Acquir Immune Defic Syndr. 2011 Apr;56(4):312-9. doi: 10.1097/QAI.0b013e31820c011a.


Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy.

Achenbach CJ, Cole SR, Kitahata MM, Casper C, Willig JH, Mugavero MJ, Saag MS.

AIDS. 2011 Mar 13;25(5):691-700. doi: 10.1097/QAD.0b013e3283437f77.


Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas.

Younes A, Bartlett NL, Leonard JP, Kennedy DA, Lynch CM, Sievers EL, Forero-Torres A.

N Engl J Med. 2010 Nov 4;363(19):1812-21. doi: 10.1056/NEJMoa1002965.


The increasing burden of HIV-associated malignancies in resource-limited regions.

Casper C.

Annu Rev Med. 2011;62:157-70. doi: 10.1146/annurev-med-050409-103711. Review.


Validity of the rapid strip assay test for detecting HBsAg in patients admitted to hospital in Uganda.

Seremba E, Ocama P, Opio CK, Kagimu M, Yuan HJ, Attar N, Thomas DL, Lee WM.

J Med Virol. 2010 Aug;82(8):1334-40. doi: 10.1002/jmv.21813.


The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma.

Dunleavy K, Little RF, Pittaluga S, Grant N, Wayne AS, Carrasquillo JA, Steinberg SM, Yarchoan R, Jaffe ES, Wilson WH.

Blood. 2010 Apr 15;115(15):3017-24. doi: 10.1182/blood-2009-11-253039. Epub 2010 Feb 3.


Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma.

Sparano JA, Lee JY, Kaplan LD, Levine AM, Ramos JC, Ambinder RF, Wachsman W, Aboulafia D, Noy A, Henry DH, Von Roenn J, Dezube BJ, Remick SC, Shah MH, Leichman L, Ratner L, Cesarman E, Chadburn A, Mitsuyasu R; AIDS Malignancy Consortium.

Blood. 2010 Apr 15;115(15):3008-16. doi: 10.1182/blood-2009-08-231613. Epub 2009 Dec 18.


Immunohistochemical and other prognostic factors in B cell non Hodgkin lymphoma patients, Kampala, Uganda.

Tumwine LK, Agostinelli C, Campidelli C, Othieno E, Wabinga H, Righi S, Falini B, Piccaluga PP, Byarugaba W, Pileri SA.

BMC Clin Pathol. 2009 Dec 16;9:11. doi: 10.1186/1472-6890-9-11.


Changing cancer incidence in Kampala, Uganda, 1991-2006.

Parkin DM, Nambooze S, Wabwire-Mangen F, Wabinga HR.

Int J Cancer. 2010 Mar 1;126(5):1187-95. doi: 10.1002/ijc.24838.


UK-based real-time lymphoproliferative disorder diagnostic service to improve the management of patients in Ghana.

Parkins E, Owen RG, Bedu-Addo G, Sem OO, Ekem I, Adomakoh Y, Bates I.

J Hematop. 2009 Jul 9;2(3):143-9. doi: 10.1007/s12308-009-0032-1.


Dose-modified oral chemotherapy in the treatment of AIDS-related non-Hodgkin's lymphoma in East Africa.

Mwanda WO, Orem J, Fu P, Banura C, Kakembo J, Onyango CA, Ness A, Reynolds S, Johnson JL, Subbiah V, Bako J, Wabinga H, Abdallah FK, Meyerson HJ, Whalen CC, Lederman MM, Black J, Ayers LW, Katongole-Mbidde E, Remick SC.

J Clin Oncol. 2009 Jul 20;27(21):3480-8. doi: 10.1200/JCO.2008.18.7641. Epub 2009 May 26.


SCT in Jehovah's Witnesses: the bloodless transplant.

Sloan JM, Ballen K.

Bone Marrow Transplant. 2008 May;41(10):837-44. doi: 10.1038/bmt.2008.5. Epub 2008 Feb 4. Review.


The spectrum of human immunodeficiency virus-associated cancers in a South African black population: results from a case-control study, 1995-2004.

Stein L, Urban MI, O'Connell D, Yu XQ, Beral V, Newton R, Ruff P, Donde B, Hale M, Patel M, Sitas F.

Int J Cancer. 2008 May 15;122(10):2260-5. doi: 10.1002/ijc.23391.


Between and within: international perspectives on cancer and health disparities.

Jones LA, Chilton JA, Hajek RA, Iammarino NK, Laufman L.

J Clin Oncol. 2006 May 10;24(14):2204-8. Review.


AIDS-related non-Hodgkin lymphoma: final analysis of 485 patients treated with risk-adapted intensive chemotherapy.

Mounier N, Spina M, Gabarre J, Raphael M, Rizzardini G, Golfier JB, Vaccher E, Carbone A, Coiffier B, Chichino G, Bosly A, Tirelli U, Gisselbrecht C.

Blood. 2006 May 15;107(10):3832-40. Epub 2006 Jan 12.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk